PUK4 AN ECONOMIC EVALUATION OF DE NOVO RENAL TRANSPLANT RECIPIENTS USING BRANDED (B-CSA) VS. NON-BRANDED CYCLOSPORINE MODIFIED (NB-CSA)
Abstract
Authors
JH Helderman AS Gilmore K Ryskina AP Legorreta C Naujoks G Machnicki
JH Helderman AS Gilmore K Ryskina AP Legorreta C Naujoks G Machnicki
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now